Ludwig, H; Kasparu, H; Greil, R; Leitgeb, C; Muldur, E; Rauch, E; Zojer, N; Autzinger, EM; Linkesch, W; Kuhr, T; Pour, L; Adam, Z; .
Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012)
Doi: 10.1182/blood.V120.21.943.943
[Keynote lecture]
Web of Science
FullText
FullText_MUG